Volume 2(Supplement 1):1-3

Slides:

Advertisements

Similar presentations

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):

Advertisements

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

Do HSCs divide asymmetrically?

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.

Next-generation leukemia immunotherapy

Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Tax fingerprint in adult T-cell leukemia

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

Nonmyeloablative conditioning for relapsed follicular lymphoma

Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.

Passage-Dependent Cancerous Transformation Of Human Mesenchymal Stem Cell Of Adipose Origin During In Vitro Culture by Jung Ah Kim, Qute Choi, Kyong Ok.

Mechanisms of HIV-associated lymphocyte apoptosis

by Satish Gopal, William A. Wood, Stephanie J. Lee, Thomas C

Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease by Caterina P. Minniti, Caroline Cantilena,

Fusion genes in cord blood

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Genetic sequence analysis of inherited bleeding diseases

Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.

by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T

Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients by Oluwagbemiga O. Ayoola, Rahman A.

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma by Mohammed A. Aljama, M. Hasib Sidiqi, Arjun.

by Lori A. Styles, Anton J. Aarsman, Elliott P. Vichinsky, and Frans A

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph.

HU for acute treatment of sickle VOC?

Volume 2(Supplement 1):63-66

Anergy: the CLL cell limbo

by John J. Strouse, Megan E. Reller, David G

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.

Activity of eltrombopag in severe aplastic anemia

Immunotherapy for acute lymphoblastic leukemia: from famine to feast

Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma by Young Ae Kim, Ja Min Byun, Keeho Park, Gi Hwan Bae, Dukhyoung.

by Seth J. Rotz, Nathan Luebbering, Bradley P

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E

Volume 2(Supplement 1):8-10

Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity by Mary Eapen, Ruta Brazauskas, Michael.

by Kaiwen Chen, Matthew P. Cheng, Sarah P

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

by Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F

by Christine L. Kempton, and Amanda B. Payne

by Terra L. Lasho, Mythri Mudireddy, Christy M. Finke, Curtis A

Volume 2(Supplement 1):46-49

by Michael R. DeBaun, and Ellen Wright Clayton

Ontogeny of platelet function

Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis by Samuel Yamshon,

Volume 2(Supplement 1):14-16

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods by Mikhail Roshal, Juan A. Flores-Montero,

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

HoxA9 directly regulates cell cycle control genes.

Bridge to transplant following Bv+Bs regimen.

Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry by Donald M. Arnold, Ishac Nazy, Rumi.

Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study by Hesham M. Eissa, Lu Lu, Malek Baassiri,

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Volume 2(Supplement 1):39-41

Sickle cells and sickle trait in thrombosis

The journey of stem cell transplantation in Bangladesh: a hike to the state of the art with collaboration between DMCH and MGH by Mafruha Akter, Mohiuddin.

CD34+ cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking by Juliet N. Barker, Jane Kempenich, Joanne.

by Sumita Ratnasingam, Patricia A. Walker, Huy Tran, Zane S

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.

Resistance mechanism for ibrutinib in marginal zone lymphoma

by Andrew L. Gilman, Michael J

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Is Skull-Base to Proximal Thigh PET/CT Enough

Volume 2(Supplement 1):4-7

Cold agglutinin disease

Presentation transcript:

Volume 2(Supplement 1):1-3 Application of a public health strategy to large-scale point-of-care screening for sickle cell disease in rural sub-Saharan Africa by C. Chunda-Liyoka, A. A. Kumar, P. Sambo, F. Lubinda, L. Nchimba, T. Humpton, P. Okuku, C. Miyanda, J. Im, K. Maguire, G. M. Whitesides, and T. P. Stossel BloodAdv Volume 2(Supplement 1):1-3 November 30, 2018 © 2018 by The American Society of Hematology

C. Chunda-Liyoka et al. Blood Adv 2018;2:1-3 © 2018 by The American Society of Hematology

C. Chunda-Liyoka et al. Blood Adv 2018;2:1-3 © 2018 by The American Society of Hematology